Lv11
20 积分 2021-01-02 加入
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
2小时前
待确认
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
2个月前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
2个月前
已完结
中国前列腺癌筛查研究报告（白皮书）
5个月前
已完结
借精准医学之力深化前列腺癌的多学科综合治疗
6个月前
已完结
借精准医学之力深化前列腺癌的多学科综合治疗
6个月前
已完结
[Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China]
7个月前
已完结
[Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China (2024 edition)]
7个月前
已完结
皖公网安备34019202002308
